-+ 0.00%
-+ 0.00%
-+ 0.00%

XENTRIA ADVANCES XTMAB-16 CLINICAL DEVELOPMENT IN PULMONARY SARCOIDOSIS FOLLOWING FDA FEEDBACK

Reuters·09/01/2026 11:01:25

Please log in to view news